Search Results - person:"Danzon, Patricia M."

Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition, and Procurement

Danzon, Patricia M.; Mulcahy, Andrew W.; Towse, Adrian K. - In: Health Economics 24 (2015) 2, pp. 238-252

This paper analyzes determinants of ex‐manufacturer prices for originator and generic drugs across countries. We focus on drugs to treat HIV/AIDS, TB, and malaria in middle and low‐income countries (MLICs), with robustness checks to other therapeutic categories and the full income range of...

Persistent link: https://www.econbiz.de/10011160879

Value-based differential pricing : efficient prices for drugs in a global context

Danzon, Patricia Munch; Towse, Adrian; Mestre … - In: Health economics 24 (2015) 3, pp. 294-301

Persistent link: https://www.econbiz.de/10011317796

Pharmaceutical pricing in emerging markets : effects of income, competition, and procurement

Danzon, Patricia Munch; Mulcahy, Andrew W.; Towse, Adrian K. - In: Health economics 24 (2015) 2, pp. 238-252

Persistent link: https://www.econbiz.de/10011317852

Pharmacy benefit management : are reporting requirements pro- or anticompetitive?

Danzon, Patricia Munch - In: International journal of the economics of business 22 (2015) 2, pp. 245-261

Persistent link: https://www.econbiz.de/10011405951

Regulation of the pharmaceutical-biotechnology industry

Danzon, Patricia Munch; Keuffel, Eric L. - In: Economic regulation and its reform : what have we learned?, (pp. 407-484). 2014

Persistent link: https://www.econbiz.de/10010373334

Effects of regulation on drug launch and pricing in interdependent markets

Danzon, Patricia Munch; Epstein, Andrew J. - 2008

"This study examines the effect of price regulation and competition on launch timing and pricing of new drugs. Our data cover launch experience in 15 countries for drugs in 12 therapeutic classes that experienced significant innovation over the decade 1992-2003. We use prices of established...